Medifast
MED
215 hedge funds and large institutions have $694M invested in Medifast in 2023 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 75 increasing their positions, 72 reducing their positions, and 39 closing their positions.
146% more capital inflows, than outflows
Capital inflows: $105M | Capital outflows: $42.8M
7.65% more ownership
Funds ownership: 87.18% → 94.84% (+7.7%)
4% more repeat investments, than reductions
Existing positions increased: 75 | Existing positions reduced: 72
4% less funds holding
Funds holding: 223 → 215 (-8)
41% less first-time investments, than exits
New positions opened: 23 | Existing positions closed: 39
47% less call options, than puts
Call options by funds: $10.7M | Put options by funds: $20.2M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Man Group
London,
United Kingdom
|
+$15.2M |
| 2 |
Pacer Advisors
Malvern,
Pennsylvania
|
+$14.1M |
| 3 |
First Trust Advisors
Wheaton,
Illinois
|
+$11.1M |
| 4 |
BlackRock
New York
|
+$8.81M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$7.92M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$7.88M |
| 2 |
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$2.99M |
| 3 |
SSCM
Summit Street Capital Management
New York
|
-$2.07M |
| 4 |
Nuveen
Charlotte,
North Carolina
|
-$2.05M |
| 5 |
Voloridge Investment Management
Jupiter,
Florida
|
-$1.95M |
MED Hedge Fund Activity: Q4 2023 in Review
215 of the 6,876 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q4 2023, worth a combined $694M — down 4.1% from $724M a quarter earlier.
Sellers outnumbered buyers: 39 funds closed out of MED and 23 opened new positions — a net loss of 16 holders — while 72 trimmed existing stakes and 75 added.
The largest buyer was Man Group, opening a new position worth an estimated $15.2M. The largest seller was Millennium Management, cutting an estimated $7.88M.
- 215 institutional investors held Medifast (MED) as of Q4 2023, down from 223 in Q3 2023.
- Funds reported $694M of Medifast stock for Q4 2023, down 4.1% quarter-over-quarter.
- 23 funds opened new Medifast positions in Q4 2023 and 39 closed out, a net change of -16 holders.
- The largest Medifast buyer in Q4 2023 was Man Group, an estimated $15.2M added.
- The largest Medifast seller in Q4 2023 was Millennium Management, an estimated $7.88M sold.
Based on aggregated 13F filings for Q4 2023.